Table 2.
List of Antigens tested in the present study.*
| Antigen | Rv# | Vaccine trial | Reference |
|---|---|---|---|
| Mtb32A | Rv0125 | Mtb72F | [131] |
| TB10.4 | Rv0288 | HyVac4, AERAS-402 | [132] |
| Mtb39A | Rv1196 | Mtb72F | [131] |
| Rv1813c | ID93 | [133,134] | |
| Ag85B | Rv1886c | H1, HyVac4, H56, AERAS-402 | [135,136] |
| Rv2608 | ID93 | [133,134] | |
| EsxV | Rv3619c | ID93 | [133,134] |
| EsxW | Rv3620c | ID93 | [133,134] |
| CFP10 | Rv3874 | ||
| ESAT-6 | Rv3875 | H1, H56 | [137–139] |
*
List of Tuberculosis antigens tested in this study. The antigens studied correspond to antigens currently considered as vaccine candidates, or included in the QuantiFERON-TB Gold In-tube test.